Categories: All postsCannabis

Green Thumb Industries is worth $24.00, Beacon Securities says

US cannabis company Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News CSE:GTII) is now well positioned in the up-and-coming state of Ohio, says Beacon Securities analyst Russell Stanley who issued an update on the company on Monday where he reiterated his “Buy” rating and C$24.00 target price.

Chicago-based Green Thumb, which has 13 manufacturing facilities, licenses for 96 retail locations and operations across 12 US markets, announced on Monday the opening of a new retail outlet in Lakewood, a suburb located seven miles west of Cleveland.

Under GTI’s Rise brand, the store represents the company’s fifth such store in Ohio (the state maximum for any one cannabis company) and the second in Lakewood, while across the country, it’s now GTI’s 43rd outlet.

“As a designated essential business during the ongoing COVID-19 crisis, we are honoured to provide cannabis to more members of the community with a second location in Lakewood,” said GTI Founder and CEO Ben Kovler in a press release. “We are grateful to be able to promote well-being through the power of cannabis, especially during these stressful and uncertain times.”

Ohio, which started selling legal medical marijuana in early 2019, while as of February 2020, the state had 88,306 registered patients for a penetration rate of less than 0.8 per cent (Ohio is the seventh-largest state in the US with a population of 11.7 million).

Stanley characterized Ohio’s start as modest but with lots of potential, a good sign for GTI.

“Should Ohio reach Arizona-like penetration rates of 2.9 per cent, Ohio’s patient count could reach 340,000 once product supply improves. We view that as achievable given a strong list of allowable conditions, with local media estimating that up to 3.5 million Ohioans could qualify for medical cannabis use,” Stanley wrote.

“More recently, sales for the week ended April 6th totalled $3.4 million, up from $2.7 million in the prior week, and implying a $175 million per year run rate. This follows record sales in March of just under $13 million. The state has issued just 57 provisional dispensary licenses to date (or one per 205,000 residents). With today’s opening, GTII owns 5 of the 51 dispensaries that have begun operations, positioning the company very well to participate in the growth of this market,” he wrote.

Outside of Ohio, Stanley noted that the municipality of Naperville, Illinois, is closer to allowing adult-use, where GTI has a currently medical-only dispensary, with management saying it hopes to make the store open for adult-use at some point in 2020.

Stanley estimates that GTI now trades at a 25 per cent discount to its US Multi-state- operator peers and at a 53-per-cent discount to its broader cannabis peer group. Looking ahead, the analyst sees Green Thumb generating fiscal 2020 revenue and attributable EBITDA of $456 million and $117 million, respectively, and fiscal 2021 revenue and attributable EBITDA of $760 million and $266 million, respectively.

His C$24 target at press time represented a projected return of 198 per cent. (All figures in US dollars except where noted otherwise.)

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: gtii
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

13 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

19 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

20 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

21 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago